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Cytochrome c oxidase (COX) catalyzes both electron transfer from cytochrome c to molecular oxygen and the
concomitant vectorial proton pumping across the inner mitochondrial membrane. Studying a large family with
multiple cases of neonatal ketoacidotic comas and isolated COX deficiency, we have mapped the disease locus to
chromosome 17p13.1, in a region encompassing two candidate genes involved in COX assembly—namely, SCO1
and COX10. Mutation screening revealed compound heterozygosity for SCO1 gene mutations in the patients. The
mutated allele, inherited from the father, harbored a 2-bp frameshift deletion (DGA; nt 363–364) resulting in both
a premature stop codon and a highly unstable mRNA. The maternally inherited mutation (C520T) changed a
highly conserved proline into a leucine in the protein (P174L). This proline, adjacent to the CxxxC copper-binding
domain of SCO1, is likely to play a crucial role in the tridimentional structure of the domain. Interestingly, the
clinical presentation of SCO1-deficient patients markedly differs from that of patients harboring mutations in other
COX assembly and/or maturation genes.
Introduction
Mitochondrial respiratory-chain deficiency is a clinically
and genetically heterogeneous condition that accounts
for an ever-increasing spectrum of clinical presentations
in humans (DiMauro et al. 1999; Wallace 2000). This
broad clinical heterogeneity stems from both the dual
genetic origin of respiratory-chain components (mtDNA
and nuclear DNA) and the number of nuclear genes
involved in the assembly and maintenance of the res-
piratory chain (Leonard and Schapira 2000b). Muta-
tions have been reported in both the mtDNA and the
nuclear genes encoding mitochondrial proteins (Leonard
and Schapira 2000a), but the molecular bases of respi-
ratory-chain deficiency remain unknown in most pa-
tients, a feature that makes genetic counseling in respir-
atory-chain deficiency particularly difficult (von Kleist-
Retzow et al. 1999).
The mitochondrial cytochrome c oxidase (COX) is
the terminal complex of the respiratory chain and cat-
alyzes electron transfer from reduced cytochrome c to
oxygen. The isolated deficiency of this enzyme is the
most frequent and clinically heterogeneous cause of re-
spiratory-chain deficiency in our series (accounting for
∼30% of those [von Kleist-Retzow et al. 1998]). This
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clinical variability is probably due to the number of
nuclear genes involved in the expression, maturation,
and assembly of the 13 COX subunits (Taanman 1997).
So far, COX deficiency has been ascribed to mutations
of either mtDNA-encoded COX subunits (Keightley et
al. 1996; Comi et al. 1998; Hanna et al. 1998; Bruno
et al. 1999; Clark et al. 1999; Rahman et al. 1999;
Hoffbuhr et al. 2000) or nuclear genes involved in
assembly of functional complexes—namely, SURF1,
SCO2, and COX10. Indeed, mutations in the nuclear
SURF1 gene (MIM 185620 and MIM 256000) usually
cause Leigh subacute necrotizing encephalomyopathy
(Zhu et al. 1998; Tiranti et al. 1999; Poyau et al. 2000)
and have occasionally been associated with other clin-
ical presentations (von Kleist-Retzow et al., in press).
On the other hand, patients harboring SCO2mutations
(MIM 604272 and MIM 604377) have presented with
encephalocardiomyopathy (Papadopoulou et al. 1999;
Jaksch et al. 2000), whereas COX10 mutations (MIM
602125) have accounted for tubulopathy and leuko-
dystrophy in one family (Valnot et al. 2000).
By studying a family with early-onset hepatic failure
and neurological involvement, we have mapped the dis-
ease locus to chromosome 17p13.1 and have ascribed
this condition to mutations of SCO1, a protein that
plays an important role for proper assembly of the
COX.
Patients and Methods
Patients
A boy (patient II.1) born to unrelated healthy parents
after a term pregnancy (birth weight 2,700 g; length 45
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Table 1
Respiratory-Chain Enzyme Activities in Liver and Muscle
Homogenate of Patient II.1 and in Controls
Patient II.1 Control
Activities (nmol/min/mg protein):
Liver (n p 26):
CI 28 11–31
CII 79 76–194
CIII 150 95–246
CIV 17 84–245
Muscle (n p 37):
CIIIII 30 19–37
CIV .5 94–196
Activity ratios:
Liver (n p 26):
CIV/CI .6 8.2  2.3
CIV/CII .2 1.6  .2
CIV/CIII .1 2.4  .2
CIII/CII 1.9 2.4  .2
Muscle (n p 37):
CIV/CIIIII .02 4.7  1.3
NOTE.—Both absolute activities and ratios are indicated.
The absence of a normal distribution of absolute control values
precluded the use of SDs. Because control activity ratios follow
a Gaussian distribution (Chretien et al. 1998), these values are
presented as mean  1 SD. Experimental conditions are as
described in the Patients and Methods section. Abnormal val-
ues are underlined.
cm; head circumference 34 cm) was found to be hypo-
tonic and lethargic and required immediate assistance
for respiratory distress. He had a severe metabolic aci-
dosis (pH 7.19; plasma bicarbonate 7.7 mM; lactate
12.7 mM normal; !2.5), with abnormally high urinary
lactate, fumarate, and succinate; hepatocellular dys-
function was noted at day 4 (factor V 25%; fibrinogen
1.2 g/liter), and he recovered thereafter. However, severe
axial hypotonia, hypoglycemia, and hyperlactatemia
(3.5 mM) persisted, and liver enlargement was observed.
Then he presented with recurrent episodes of apnea and
bradycardy and died at age 2 mo. For investigation of
respiratory-chain activities, immediate postmortem liver
and skeletal muscle biopsies were performed, and blood
lymphocytes were isolated. Histopathological exami-
nation of the liver showed swollen hepatocytes, with
microvesicular lipid vacuoles and panlobular steatosis.
Furthermore, histological study of a muscle-biopsy sam-
ple revealed an accumulation of lipid droplets. One year
later, a second boy was born at week 34 of pregnancy
(patient II.2; birth weight 1,750 g). He presented with
a severe neurological distress and metabolic acidosis and
died at age 5 d.
Methods
Enzyme assays.—COX (E.C.1.9.3.1), succinate qui-
none DCPIP reductase, and succinate cytochrome c re-
ductase activities were measured spectrophotometrically
on tissue homogenates, as described elsewhere (Rustin
et al. 1994).
DNA analyses.—DNA was extracted from leuko-
cytes, muscle, or chorionic villus biopsies. For genotyp-
ing, microsatellite markers from the Ge´ne´thon database
were used (Dib et al. 1996). For chromosomeXmarkers,
the PCR products were loaded onto a polyacrylamide
gel and were transferred to a positive nylon membrane
(Nytran plus; Schleicher and Schuell). Membranes were
hybridized with a (CA)12 probe. The labeling of the
probe and the revelation of the blots were performed
using the ECL direct nucleic acid–labeling and –detec-
tion system (Amersham Pharmacia Biotech). The blots
were autoradiographed with Kodak-X-OMAT films for
2–30 min.
For the genomewide search, 382 pairs of fluorescent
oligonucleotides from the GENESCAN linkagemapping
set, version 2 (PE Biosystems), were used under condi-
tions recommended by the manufacturer. Amplified frag-
ments were electrophoresed and analyzed with an au-
tomatic sequencer (ABI 377). The polymorphic markers
had an average spacing of 10 cM throughout the ge-
nome. Linkage analysis was performed using M-LINK
and LINKMAP, version 5.1.
Sequence analysis.—The six exons of the SCO1 gene
(MIM 603644) were amplified by PCR using the fol-
lowing SCO1-specific intronic primers (forward/reverse,
5′r3′)—exon 1, TACCGGAAATCGCGGGGA and AG-
AAGGGTTCCAGGTGTGC; exon 2, TTTATGTTTG-
AAATCCCTGCC and TACAGGGCTGAGCAGATG-
AT; exon 3, TGTCGATATGTTTTTGTCTCCT and
CTTTGTTTAGTTAGTGATGGCT; exon 4, TTAG-
GGTGTGAATACGGAC and AGGCACTGTAAGGT-
TCAAAT; exon 5, TAGAGATGGTTGTTTTACTGG
and TGGTCCATGGGTTAAAACTG; and exon 6, TT-
GGTAATCTTTGTCACACTC and TTAGCAAGAG-
AATACTGCATC. Amplification products were electro-
phoresed through a 2% low-melting-point agarose gel,
were purified, and were directly sequenced using the
PRISM Ready Reaction Sequencing Kit (PE Biosystems)
on an automatic sequencer (ABI 373; PE Biosystems).
SSCP analysis was performed using the GeneGel Excel
12.5/24 kit from Pharmacia. Exon 3 primers were used
to amplify a 253-bp fragment surrounding the C520T
mutation that creates a XbaI restriction site. The XbaI
restriction fragments were separated on a 3% agarose
gel.
Results
Enzymological Studies
A severe isolated COX deficiency with markedly al-
tered activity ratios was found in a postmortem liver-
biopsy sample from patient II.1 (table 1). The same en-
zyme deficiency was found in skeletal muscle and
circulating lymphocytes of both the patient (not shown)
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Figure 1 Pedigree and haplotype analyses. Haplotypes are given
for loci D17S938, D17S1852, D17S799, and D17S921 (top to
bottom).
Figure 2 Sequence analysis of SCO1. A, Paternally inherited
frameshift mutation in exon 2. B, Maternally inherited mutation in
exon 3.
and his younger brother (patient II.2; not shown). Sub-
sequently, two prenatal diagnoses were performed, and
the two male fetuses showed COX deficiency, in both
chorionic villi and amniotic cell fluid, at weeks 11 and
16 of pregnancy, respectively.
Genetic Studies
Before the birth of individual II.6, the observation of
four affected males (two neonates and two fetuses) and
a healthy girl in a nonconsanguineous family was con-
sistent with either a maternal or an X-linked mode of
inheritance. Both screening of the mtDNA, for large re-
arrangements and common point mutations known to
cause COX deficiency (MERRF andMELASmutations),
and sequencing of mitochondrial COX genes and sur-
rounding tRNA genes failed to detect any disease-caus-
ing mtDNA mutation. Extensive genotyping using 40
microsatellite DNA markers of chromosome X excluded
an X-linked mode of inheritance in this family (not
shown).
A genomewide linkage search revealed that the four
affected individuals carried an identical genotype at lo-
cus D17S1852 on chromosome 17, whereas the two
healthy sibs carried different haplotypes at this locus (fig.
1). No other region of haploidentity was identified.
Screening for Mutations in the SCO1 Gene
Two genes were regarded as excellent candidates, by
virtue of both position and function. The COX10 gene
maps to human chromosome 17p13 and encodes a heme
A:farnesyltransferase involved in the assembly of the
COX I prosthetic group. This gene has recently been
shown to account for COX deficiency in a family with
tubulopathy and encephalomyopathy (Valnot et al.
2000). On the other hand, SCO1 also maps to chro-
mosome 17p13 and codes for a protein involved in mi-
tochondrial copper import and/or insertion into COX.
In yeast, mutations in either genes are known to result
in the absence of functional heme in COX. Because an
informative intragenic polymorphism allowed us to ex-
clude COX10 (not shown), a search for mutations in
the SCO1 gene was undertaken by directly sequencing
the six exons of the gene. All affected individuals were
compound heterozygotes for SCO1 mutations. A 2-bp
deletion (DGA; nt 363–364), inherited from the father,
resulted in both a frameshift and a premature stop codon
in exon 2 (figs. 2A and 3B). The mutated mRNA was
predicted to encode a truncated protein missing the func-
tionally conserved putative core region of the enzyme
and was highly unstable, since it could not be detected
by reverse transcription–PCR amplification of the pa-
tient’s liver RNA (fig. 3A). A second allelic mutation,
inherited from the mother, was found in exon 3 of the
SCO1 gene (figs. 2B and 3C). This mutation, a CrT
transition at nt 520, changed a highly conserved proline
into a leucine in the protein (P174L; fig. 3D). This pro-
line is also conserved in human and yeast SCO2, a mi-
tochondrial protein that is highly homologous to SCO1
and that is also involved in copper insertion within
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Figure 3 Molecular analysis of SCO1 mutations. A, Sequence analysis of cDNA of patient II.1. B, SSCP screening for the paternally
inherited frameshift mutation in the family. C, Screening of the maternally inherited mutation (C520T) in exon 3 by XbaI restriction analysis.
D, Sequence alignment of the SCO1 protein from patient II.1, from controls, and from nonhuman sources, as well as of human and yeast
SCO2 proteins. F p father; M p mother; C p control; ND p nondigested control; MW p molecular weight.
COX. The P174L transition created a XbaI restriction
site and was absent from 110 controls of the same ethnic
origin. No SCO1, SCO2, or COX10 mutations were
found in 18 patients with isolated COX deficiency and
similar clinical presentation.
Discussion
Combining conventional linkage analysis and the can-
didate-gene approach in a nonconsanguineous family
with multiple cases of neonatal-onset hepatic failure and
ketoacidotic comas, we have shown here that mutations
in the COX-assembly gene SCO1 can cause severe iso-
lated COX deficiency.
The SCO1 gene product is believed to transfer copper
from Cox17p, a copper-binding protein of the cytosol
and mitochondrial intermembrane space, to the mito-
chondrial COX subunit II. Mutational analyses of the
yeast SCO1 gene have shown that the CxxxC copper-
binding motif is essential for the protein function, since
mutant proteins failed to restore the respiratory com-
petence of the sco1 null mutant (Rentzsch et al. 1999).
The human cDNA counterpart has been identified by
sequence homology with the yeast SCO1 gene (Petru-
zella et al. 1998). The human and yeast proteins share
a 40% identity, suggesting a similar function of the pro-
tein in the two organisms. The patients reported here
were compound heterozygotes for a frameshift muta-
tion resulting in both a premature stop codon and a
proline-to-leucine missense mutation immediately ad-
jacent to the CxxxC copper-binding motif, in a highly
conserved domain of the SCO1 protein. Because pro-
lines are known to bend proteins, this substitution in a
highly conserved region may interfere with the function
of SCO1, modifying the tertiary structure of the copper-
binding domain. These data suggest that the missense
mutation combined with the loss of function of the sec-
ond SCO1 allele is responsible for the isolated COX
deficiency in this family.
Interestingly, another SCO-like protein, SCO2, has
been identified in both humans and yeast. SCO1 and
SCO2 are highly homologous, since the proteins share
a 40% identity, especially in the core region of the pro-
tein. Although the respective roles of the two proteins
remain to be fully established, several lines of evidence
suggest that both proteins are involved in mitochondrial
copper trafficking from the intermembrane space to the
inner mitochondrial membrane, copper being initially
directed to the mitochondria by Cox17p (Glerum et al.
1996). The two SCO proteins are similarly associated
with the inner mitochondrial membrane (Buchwald et
al. 1991; Glerum et al. 1996; Paret et al. 1999), and
overexpression of either SCO1 or SCO2 partially res-
cues a Cox17 null–mutant yeast strain, suggesting a
partial functional redundancy of these two genes
(Glerum et al. 1996). Finally, the SCO1 and SCO2 genes
present a largely similar pattern of expression in human
tissues (Papadopoulou et al. 1999).
Recently, mutations in the SCO2 gene have been re-
ported in COX-deficient patients with cardioencephalo-
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myopathy (Papadopoulou et al. 1999; Jaksch et al.
2000). Moreover, a recurrent mutation converted a glu-
tamic acid into a lysine (E140K) in the region surround-
ing the CxxxC copper-binding domain of the SCO2
protein and was believed to displace copper from the
copper-binding domain. This glutamic acid corresponds
to amino acid residue 176 in the human SCO1 protein
and is very close to the modified proline identified in
our patients (residue 174).
The clinical consequences of the SCO1mutations are
markedly different from those caused by mutations in
the functionally related SCO2 gene. Indeed, SCO1mu-
tations caused neonatal hepatic failure and ketoacidotic
comas as the onset symptoms, whereas SCO2mutations
developed hypertrophic cardiomyopathy and hypotonia
during the first weeks of life. Whether the clinical dis-
crepancies between closely related gene mutations are
significant, fortuitous, or related to the small number
of reported cases is still debatable.
To date, mutations in four nuclear genes involved in
maturation or assembly of COX have been identified
in humans—namely, SURF1, COX10, SCO1, and
SCO2. All four gene mutations caused severe isolated
COX deficiency, with an abnormal pattern of COX sub-
units. Again, no correlation between mutant genotypes
and clinical phenotypes could be made. Indeed, patients
with SURF1 mutations presented with Leigh syndrome
(Zhu et al. 1998; Tiranti et al. 1999), SCO2 muta-
tions caused cardioencephalomyopathy (Papadopou-
lou et al. 1999; Jaksch et al. 2000), and COX10
mutations caused tubulopathy and encephalopathy,
whereas SCO1 mutations caused neonatal hepatic fail-
ure and ketoacidotic comas. The onset of the disease
was consistently very early, with no symptom-free pe-
riod, suggesting an antenatal expression of the disease.
Expression studies have shown that SURF1 (Yao and
Shoubridge 1999), SCO1, and SCO2 (Papadopoulou et
al. 1999) are ubiquitously expressed in human adult
tissues, the higher expression being observed in mito-
chondria-rich tissues—namely, heart, skeletal muscle,
liver, and kidney. However, brain shows a lower ex-
pression, compared with the highly aerobic tissues men-
tioned above. On the contrary, COX10 is highly ex-
pressed in skeletal muscle, heart, and testis but is less
highly expressed in liver and kidney, whereas patients
with COX10 presented with tubulopathy and enceph-
alopathy (Murakami et al. 1997). The variations, in
the steady-state levels of the four COX assembly–gene
mRNAs, among adult tissues cannot be related to the
clinical expression of the SURF1-, SCO1-, SCO2-, and
COX10-deficient patients. Thus, one can hypothesize
that the different clinical presentations are related to
different patterns of expression of the genes during em-
bryonic or fetal life. Studying the temporospatial ex-
pression pattern of these four genes, as well as other
COX-assembly genes in human embryos, will help in
the elucidation of both their respective requirement dur-
ing development and the variable clinical presentations
of the patients.
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